Skip to content
Company Analysis

PAVmed Inc. PAVM

A comprehensive view of key metrics, scores, and financial health for PAVmed Inc.

Overview of PAVmed Inc.

PAVM NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
PAVmed Inc. (PAVM), is a Micro Cap company, in the Medical Devices industry, last closed at $4.72, about 0.0% overvalued vs fair value, -62.5% 1Y return, ranked 995/1145 in sector.
Metrics Rev Growth -97.6% ROE 2.6% Gross Margin -207.0%
USD 4.72
-10.61%
(Delayed)
• Vol 90d: 88.3%
52-Week Range
Market Cap
$40.40M
Enterprise Value
$53.68M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Fair
Profitability
Fair
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 94%
Confidence: 59%
Updated: Sep 12
Top Beats
No strong beats yet

Quick Facts

Website https://www.pavmed.com
HQ New York, NY
Employees 39
Fiscal year Dec 31

Next Events

Earnings Nov 12

Fair Value Snapshot

Bear Base Bull
$0
$0
$0
Current: $4.72

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$71.0K
-97.6%%
Gross Profit
$-147.0K
92%%
Operating Income (GAAP)
$-21.4M
51.8%%
EBITDA
$-2.3M
-107.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
-207.0%
Poor

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
3
Active Leaks
1/3
Improving
0
High Impact
3
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating PAVmed Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
15
/100
Weak
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Above-Peer Asset Productivity Asset productivity is strong vs peers (score 1.00). Above-peer ROA underpins the growth durability narrative.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.02). May indicate commodity-like product mix or distributor margin drag.
  • Weak FCF Generation FCF margin quality lags peers (score 0.04). Below-peer FCF conversion is a MedTech quality warning.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Weak
3
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing PAVM's balance between Growth (17.7%), Profitability (21.8%), and Safety (60.5%). Growth 18% Safety 61% Profitability 22%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

11th percentile vs peers
12
Key Signals
Asset Growth YoY 26.6% 87p EPS Growth YoY -1.05 10p Rev Growth YoY -97.6% 4p Revenue CAGR 3Y -42.7% 4p
Strengths

No notable strengths identified for this axis.

Risks
  • Growth in bottom 20% of peers (percentile: 11)
  • EPS Growth YoY in bottom 20% of peers (-1.05)
  • Rev Growth YoY in bottom 20% of peers (-97.6%)

Profitability

14th percentile vs peers
14
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

39th percentile vs peers
40
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for PAVmed Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-0.49
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000